Developer docs
API playgroundTry for free, no card

Search company profiles

Genova Diagnostics

Full company profile

uuid0007yhr

Namestring
Genova Diagnostics
Legal namestring
Genova Diagnostics Inc.
Websiteurl
gdx.net
Company typeenum
Private
Founded yearint
1985
Descriptiontext

Genova Diagnostics is a privately held clinical laboratory founded in 1985 and headquartered in Asheville, North Carolina, that provides specialty diagnostic testing primarily to licensed healthcare providers (MDs, DOs, DCs, NDs, NPs) and, through its direct-to-consumer Genova Connect platform, to individual patients. The company operates across gut health, nutrition, hormonal health, immune function, and specialty testing categories, with a portfolio of 19+ branded products including GI Effects (multi-method stool profile), Microbiomix (metagenomic whole-genome sequencing via partner Microba), NutrEval (125+ biomarkers), Metabolomix+, SIBO breath testing, One Day Hormone Check, and the newly launched Alzheimer's Assessment (p-Tau217). Underlying testing combines PCR, culture, microscopy, MALDI-TOF MS, metagenomic sequencing, and immunoassay methodologies, analyzed against Genova's proprietary 28,000+ species reference database and interpreted using its inflammatory and methane dysbiosis scoring algorithms.

The business model is transaction-based: providers or patients pay per test through a combination of commercial insurance billing (Genova is in-network with CareFirst Blue Cross Blue Shield and Blue Shield of California, and participates in Medicare and Tricare), provider Net-30 billing, and direct patient cash pay with HSA/FSA acceptance and interest-free installment plans for tests over $150. The myGDX portal serves as the clinician-facing platform for ordering, EHR integration, and result delivery, while Genova Connect extends access to non-prescriber consumers. A mobile phlebotomy partnership with Getlabs adds at-home and office blood draw capability at a $90 per-draw fee. The company states 40 years of clinical use, analysis of more than 300 biomarkers across major functional systems, and international reach across the US, UK, and additional markets, with certain geographic restrictions (e.g., select products unavailable in New York; practitioner pay unavailable in NJ and RI).

Genova holds HIPAA and GDPR compliance frameworks, files claims across major payer categories (excluding Medicaid), and is a privately held corporate entity (Genova Diagnostics Inc., North Carolina) with no disclosed parent company, funding rounds, or institutional ownership. No public revenue, headcount, or financial performance figures are disclosed in available sources.

Short descriptiontext

Genova Diagnostics is a privately held specialty clinical laboratory founded in 1985 that provides functional medicine diagnostic testing — including stool, nutritional, hormonal, and specialty biomarker panels — to licensed healthcare providers and direct-to-consumer patients across the US, UK, and international markets via its myGDX and Genova Connect platforms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersAsheville, United States
HQ citystring
Asheville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory diagnostics, functional medicine testing, gut microbiome testing, specialty diagnostic services, hormone testing services
Industry3 codes
1Molecular Diagnostics & Genomics Laboratories
CodeHLAFAMAEPrimaryYes
2Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
CodeHLAAALADPrimaryNo
3Genetic & Prenatal Testing Laboratories
CodeHLAFAMAHPrimaryNo
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Laboratory Diagnostics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Laboratory Diagnostic Testing Services
TypeTransaction Fee
Description

Core revenue from laboratory testing services for healthcare providers and patients. Tests are billed per test with pricing dependent on specific profiles, panels, and add-ons ordered. Revenue generated through direct patient pay, insurance billing, Medicare/Tricare, and provider billing (Net 30).

gdx.net
2Insurance and Medicare Billing
TypeTransaction Fee
Description

Genova files claims to commercial insurance plans (including Medicare Advantage) and participates with Medicare and Tricare. Initial patient payments are collected at activation with additional billing after insurance processing.

gdx.net
3Patient Direct Pay
TypeTransaction Fee
Description

Cash pay option for uninsured patients or those choosing to file claims themselves. Includes interest-free payment plan (up to 4 installments) for tests over $150. HSA and FSA funds accepted.

gdx.net
4Provider/Clinician Billing
TypeSubscription Recurring
Description

Healthcare providers can be billed at Net 30 terms or place credit card on file for automatic payment upon test completion or monthly account balance charging.

gdx.net
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Insurance Billing with Initial Payment
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Patients make an initial payment when activating test. Genova files insurance claim, and if additional patient responsibility exists after processing, a statement is sent. Discounts available for prompt payment (not available in FL or NY).

gdx.net
2Interest-Free Payment Plan
ModelTransaction based/ take rateBilling cadenceMonthly
Notes

For tests over $150, cost can be distributed across up to 4 equal installments. Initial payment charged upon specimen receipt, remaining balance auto-charged monthly to credit card.

gdx.net
3Single Full Payment
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Full cash payment with specimen submission results in no additional bills after testing. HSA and FSA funds accepted.

gdx.net
4Mobile Phlebotomy Draw Fee
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$90 fee paid to Getlabs for at-home or office blood draw. This is separate from Genova lab test pricing and paid at booking.

gdx.net
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 13 records shown
1GI Effects
Description

Comprehensive stool profile testing for gut health assessment including digestion, inflammation, and microbiome analysis

gdx.net
+12 more records
Core offering1 text field

Genova Diagnostics is a clinical laboratory that performs advanced specialty diagnostic testing for personalized health, analyzing 300+ biomarkers across gut health, nutrition, hormonal health, immune function, and specialty domains. Tests are ordered primarily by licensed healthcare providers through the myGDX portal and are also accessible directly to consumers through Genova Connect, with specimens (stool, blood, urine, saliva, breath, buccal) processed at the company's Asheville, NC laboratory.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Analysis of more than 300 clinically relevant biomarkers
+2 more records
Product overview1 text field

Genova Diagnostics is a clinical laboratory offering advanced diagnostic testing for personalized health. The portfolio includes multiple testing categories: Gut Health (GI Effects®, SIBO, Microbiomix™), Nutrition (NutrEval®, Metabolomix+®, Methylation Panel, Organix, Fatty15), Hormonal Health (Adrenocortex Stress Profile, One Day Hormone Check™, Women's Health+, Endo+, Comprehensive Thyroid Assessment, Comprehensive Melatonin Profile), Immune Function (Alcat Test, Food Sensitivity+, Celiac Profile), and Specialty (Alzheimer's Assessment p-Tau217, Cardio Check, DetoxiGenomic Profile). The core platform is the myGDX provider portal for test ordering and results. Testing utilizes multiple specimen types including stool, breath, urine, blood, saliva, and buccal swabs. Many tests are available with add-on modules such as Microbiomix for enhanced microbiome analysis and IgG Food Antibodies for comprehensive immune assessment.

Product and service18 records
1GI Effects® Comprehensive Stool Profile
CategoryGut Health Diagnostic Testing
Description

Comprehensive stool profile for healthcare providers and patients assessing gut health through digestion, inflammation, and microbiome markers using multi-method testing combining PCR, culture, and microscopy to identify digestive function, intestinal inflammation, and commensal/pathogenic organisms.

2Microbiomix™
CategoryGut Health Diagnostic Testing
Description

Metagenomic stool analysis using whole-genome shotgun sequencing to assess complete gut microbiome and functional potential for clinicians and patients; available as standalone profile or add-on to GI Effects Comprehensive.

3SIBO Breath Test
CategoryGut Health Diagnostic Testing
Description

Non-invasive hydrogen and methane breath test measuring gases following lactulose ingestion to evaluate small intestinal bacterial overgrowth and intestinal methanogen overgrowth; available in 2-hour and 3-hour formats for healthcare providers and patients.

4NutrEval®
CategoryNutrition Diagnostic Testing
Description

Comprehensive nutritional profile using blood and urine to evaluate 125+ biomarkers and assess functional need for 40 antioxidants, vitamins, minerals, essential fatty acids, amino acids, and digestive support; available in FMV and Plasma versions for clinicians and patients.

5Metabolomix+®
CategoryNutrition Diagnostic Testing
Description

Non-invasive at-home nutritional test using first morning void urine collection with optional bloodspot finger stick and buccal swab for clinicians and patients; analyzes organic acids, amino acids, fatty acids, and oxidative stress markers.

6Methylation Panel
CategoryNutrition Diagnostic Testing
Description

Combined phenotypic and genotypic assessment of the biochemical methylation pathway using plasma metabolites and buccal swab genetic SNPs (MTHFR, COMT, TNF-a, APOE) for detoxification, mood, cardiovascular health, and energy production insights.

7Adrenocortex Stress Profile
CategoryHormonal Health Diagnostic Testing
Description

Salivary hormone test assessing the HPA axis through four timed cortisol and DHEA samples across the day to evaluate diurnal cortisol rhythm and adrenal function for clinicians and patients.

8One Day Hormone Check™
CategoryHormonal Health Diagnostic Testing
Description

24-hour salivary hormone test evaluating unbound bioavailable levels of estradiol, estrone, estriol, progesterone, testosterone, cortisol, DHEA, and melatonin in women and men.

9Women's Health+
CategoryHormonal Health Diagnostic Testing
Description

Integrated metabolic and endocrine profile combining hormone panels, organic acid nutritional markers, and optional genetic SNPs using saliva, urine, and buccal swab samples for women's health.

10Endo+
CategoryHormonal Health Diagnostic Testing
Description

Comprehensive customizable hormonal assessment evaluating thyroid, adrenal, melatonin, and sex hormones along with estrogen metabolism using saliva, serum, or urine samples.

11Alzheimer's Assessment (p-Tau217)
CategorySpecialty Diagnostic Testing
Description

Single-draw blood assessment measuring plasma p-Tau217 for early detection of Alzheimer's-related pathology (amyloid plaques and tau tangles) to support clinical decision-making.

12Alcat Test
CategoryImmune Function Diagnostic Testing
Description

Leukocyte reactivity test assessing immune response to foods, additives, chemicals, and other substances for personalized nutrition strategies; newly added to Genova's Immune Function testing menu in 2025.

13Cardio Check
CategorySpecialty Diagnostic Testing
Description

Cardiovascular health assessment panel offered under the Specialty testing category for clinicians and patients.

14DetoxiGenomic Profile
CategorySpecialty Diagnostic Testing
Description

Genomic assessment of detoxification pathways offered under the Specialty testing category for clinicians and patients.

15Food Sensitivity+
CategoryImmune Function Diagnostic Testing
Description

IgG and IgE antibody profile measuring immune responses to commonly consumed foods and environmental allergens, available as a standalone or add-on to GI Effects, Metabolomix+, and Organix.

16Celiac Profile
CategoryImmune Function Diagnostic Testing
Description

Comprehensive testing for celiac disease markers offered under the Immune Function category for clinicians and patients.

17myGDX Provider Portal
CategoryProvider Platform / Distribution Channel
Description

Web-based provider portal for licensed healthcare professionals to order Genova Diagnostic tests, view pricing, track order status, and access results reports, with cloud-based EHR integration for streamlined ordering and results transmission.

18Genova Connect (Direct-to-Consumer Storefront)
CategoryConsumer Platform / Distribution Channel
Description

Online direct-to-consumer storefront at connect.gdx.net for individuals to purchase select gut health, nutrition, and hormonal health tests without a physician order, with optional provider matching for result interpretation.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

Genova collaborates with Microba, who provides world-leading technology in metagenomic analysis and interpretation for the Microbiomix stool analysis product. Microba's Analysis Platform enables detection of over 28,000 species through their unmatched reference database. This partnership enables Genova to offer the most comprehensive gut microbiome testing combining biomarker analysis with genotypic data.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Doctor's Data is a specialty clinical laboratory offering stool-based GI testing, toxic element analysis, and other functional medicine diagnostics. It is one of the closest direct competitors to Genova in the functional/integrative medicine lab space, overlapping on microbiome and nutritional assessment offerings.

TypeDirect peer
Description

Mosaic Diagnostics is a specialty lab focused on comprehensive stool parasitology, organic acids, and environmental toxin testing serving integrative and functional medicine practitioners. Direct overlap with Genova in gut health, nutrition, and specialty biomarker panels and target clinician base.

TypeDirect peer
Description

ZRT Laboratory specializes in hormone and wellness testing using dried blood spot, saliva, and serum, sold primarily through healthcare providers. Strong overlap with Genova's hormonal health portfolio (Adrenocortex Stress Profile, One Day Hormone Check, Women's Health+).

TypeDirect peer
Description

Vibrant offers advanced specialty lab testing including food sensitivity, hormones, and gut health panels via provider channels and direct-to-consumer options. Competes head-to-head with Genova in functional medicine and DTC lab testing with strong digital/marketing capabilities.

TypeDirect peer
Description

SpectraCell is a clinical laboratory specializing in micronutrient testing, cardiovascular risk panels, and immune-related diagnostics marketed to integrative and preventive medicine practitioners. Overlaps with Genova's NutrEval/Metabolomix nutritional assessment category.

TypeDirect peer
Description

Boston Heart Diagnostics is a specialty lab focused on advanced cardiovascular disease diagnostics sold through healthcare providers. Overlaps with Genova's specialty testing category (Cardio Check) and provider-led specialty lab model.

TypeBroad incumbent
Description

Quest Diagnostics is a large national reference laboratory offering routine and specialty diagnostics across endocrinology, gastroenterology, and genetics. As a broad incumbent, Quest could expand into functional-medicine-adjacent specialty testing and compete on insurance coverage, logistics, and brand.

TypeBroad incumbent
Description

Labcorp is a national reference lab with a growing portfolio in women's health, hormone, and specialty testing. As a broad incumbent with extensive payer contracts and phlebotomy infrastructure, Labcorp represents the scale-tier threat to Genova's niche functional diagnostics.

TypeOthers
Description

Microba is Genova's metagenomics technology partner whose Analysis Platform underlies the Microbiomix product. They are adjacent (enabling partner) rather than a direct competitor today, but they are a credible emerging player in gut microbiome analysis that could enter clinical lab services.

TypeEmerging player
Description

Access Medical Labs provides specialty diagnostics including hormones, infectious disease, and wellness panels with nationwide servicing. Overlaps with Genova's specialty/hormonal testing menu and competes for provider relationships in the DTC-adjacent segment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genova Diagnostics

Clinical Laboratory Diagnosticsgdx.net

Genova Diagnostics is a privately held specialty clinical laboratory founded in 1985 that provides functional medicine diagnostic testing — including stool, nutritional, hormonal, and specialty biomarker panels — to licensed healthcare providers and direct-to-consumer patients across the US, UK, and international markets via its myGDX and Genova Connect platforms.

What Genova Diagnostics does

Genova Diagnostics is a privately held clinical laboratory founded in 1985 and headquartered in Asheville, North Carolina, that provides specialty diagnostic testing primarily to licensed healthcare providers (MDs, DOs, DCs, NDs, NPs) and, through its direct-to-consumer Genova Connect platform, to individual patients. The company operates across gut health, nutrition, hormonal health, immune function, and specialty testing categories, with a portfolio of 19+ branded products including GI Effects (multi-method stool profile), Microbiomix (metagenomic whole-genome sequencing via partner Microba), NutrEval (125+ biomarkers), Metabolomix+, SIBO breath testing, One Day Hormone Check, and the newly launched Alzheimer's Assessment (p-Tau217). Underlying testing combines PCR, culture, microscopy, MALDI-TOF MS, metagenomic sequencing, and immunoassay methodologies, analyzed against Genova's proprietary 28,000+ species reference database and interpreted using its inflammatory and methane dysbiosis scoring algorithms.

The business model is transaction-based: providers or patients pay per test through a combination of commercial insurance billing (Genova is in-network with CareFirst Blue Cross Blue Shield and Blue Shield of California, and participates in Medicare and Tricare), provider Net-30 billing, and direct patient cash pay with HSA/FSA acceptance and interest-free installment plans for tests over $150. The myGDX portal serves as the clinician-facing platform for ordering, EHR integration, and result delivery, while Genova Connect extends access to non-prescriber consumers. A mobile phlebotomy partnership with Getlabs adds at-home and office blood draw capability at a $90 per-draw fee. The company states 40 years of clinical use, analysis of more than 300 biomarkers across major functional systems, and international reach across the US, UK, and additional markets, with certain geographic restrictions (e.g., select products unavailable in New York; practitioner pay unavailable in NJ and RI).

Genova holds HIPAA and GDPR compliance frameworks, files claims across major payer categories (excluding Medicaid), and is a privately held corporate entity (Genova Diagnostics Inc., North Carolina) with no disclosed parent company, funding rounds, or institutional ownership. No public revenue, headcount, or financial performance figures are disclosed in available sources.

Genova Diagnostics firmographics

Firmographics
Name
Genova Diagnostics
Legal name
Genova Diagnostics Inc.
Website
https://gdx.net
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
251–500 employees
Short description
Genova Diagnostics is a privately held specialty clinical laboratory founded in 1985 that provides functional medicine diagnostic testing — including stool, nutritional, hormonal, and specialty biomarker panels — to licensed healthcare providers and direct-to-consumer patients across the US, UK, and international markets via its myGDX and Genova Connect platforms.
Ownership category
akta.pro rank

Genova Diagnostics industry classification

Industry
Product category
Clinical Laboratory Diagnostics
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
akta.pro secondary industries
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genetic & Prenatal Testing Laboratories (HLAFAMAH)

Keywords

  • Clinical laboratory diagnostics
  • Functional medicine testing
  • Gut microbiome testing
  • Specialty diagnostic services
  • Hormone testing services

Where Genova Diagnostics is headquartered

Location

Headquarters

HQ city
Asheville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Genova Diagnostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Laboratory Diagnostic Testing Services: Core revenue from laboratory testing services for healthcare providers and patients. Tests are billed per test with pricing dependent on specific profiles, panels, and add-ons ordered. Revenue generated through direct patient pay, insurance billing, Medicare/Tricare, and provider billing (Net 30).
  2. Insurance and Medicare Billing: Genova files claims to commercial insurance plans (including Medicare Advantage) and participates with Medicare and Tricare. Initial patient payments are collected at activation with additional billing after insurance processing.
  3. Patient Direct Pay: Cash pay option for uninsured patients or those choosing to file claims themselves. Includes interest-free payment plan (up to 4 installments) for tests over $150. HSA and FSA funds accepted.
  4. Provider/Clinician Billing: Healthcare providers can be billed at Net 30 terms or place credit card on file for automatic payment upon test completion or monthly account balance charging.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goInsurance Billing with Initial Payment
Transaction based/ take rateMonthlyInterest-Free Payment Plan
One time/ perpetual licensePay-as-you-goSingle Full Payment
Unit PricingPay-as-you-goMobile Phlebotomy Draw Fee

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Genova Diagnostics product offering

Product offering

Core offering

Genova Diagnostics is a clinical laboratory that performs advanced specialty diagnostic testing for personalized health, analyzing 300+ biomarkers across gut health, nutrition, hormonal health, immune function, and specialty domains. Tests are ordered primarily by licensed healthcare providers through the myGDX portal and are also accessible directly to consumers through Genova Connect, with specimens (stool, blood, urine, saliva, breath, buccal) processed at the company's Asheville, NC laboratory.

Product overview

Genova Diagnostics is a clinical laboratory offering advanced diagnostic testing for personalized health. The portfolio includes multiple testing categories: Gut Health (GI Effects®, SIBO, Microbiomix™), Nutrition (NutrEval®, Metabolomix+®, Methylation Panel, Organix, Fatty15), Hormonal Health (Adrenocortex Stress Profile, One Day Hormone Check™, Women's Health+, Endo+, Comprehensive Thyroid Assessment, Comprehensive Melatonin Profile), Immune Function (Alcat Test, Food Sensitivity+, Celiac Profile), and Specialty (Alzheimer's Assessment p-Tau217, Cardio Check, DetoxiGenomic Profile). The core platform is the myGDX provider portal for test ordering and results. Testing utilizes multiple specimen types including stool, breath, urine, blood, saliva, and buccal swabs. Many tests are available with add-on modules such as Microbiomix for enhanced microbiome analysis and IgG Food Antibodies for comprehensive immune assessment.

Differentiator

Problem solved

Functional benefit

Brands

  • GI Effects: Comprehensive stool profile testing for gut health assessment including digestion, inflammation, and microbiome analysis
  • NutrEval
  • Metabolomix+
  • SIBO
  • Microbiomix
  • Methylation Panel
  • Adrenocortex Stress Profile
  • One Day Hormone Check
  • Women's Health+
  • Alcat Test
  • Genova Connect
  • myGDX
  • Endo+

Products and services

  • GI Effects® Comprehensive Stool Profile Comprehensive stool profile for healthcare providers and patients assessing gut health through digestion, inflammation, and microbiome markers using multi-method testing combining PCR, culture, and microscopy to identify digestive function, intestinal inflammation, and commensal/pathogenic organisms.
  • Microbiomix™ Metagenomic stool analysis using whole-genome shotgun sequencing to assess complete gut microbiome and functional potential for clinicians and patients; available as standalone profile or add-on to GI Effects Comprehensive.
  • SIBO Breath Test Non-invasive hydrogen and methane breath test measuring gases following lactulose ingestion to evaluate small intestinal bacterial overgrowth and intestinal methanogen overgrowth; available in 2-hour and 3-hour formats for healthcare providers and patients.
  • NutrEval® Comprehensive nutritional profile using blood and urine to evaluate 125+ biomarkers and assess functional need for 40 antioxidants, vitamins, minerals, essential fatty acids, amino acids, and digestive support; available in FMV and Plasma versions for clinicians and patients.
  • Metabolomix+® Non-invasive at-home nutritional test using first morning void urine collection with optional bloodspot finger stick and buccal swab for clinicians and patients; analyzes organic acids, amino acids, fatty acids, and oxidative stress markers.
  • Methylation Panel Combined phenotypic and genotypic assessment of the biochemical methylation pathway using plasma metabolites and buccal swab genetic SNPs (MTHFR, COMT, TNF-a, APOE) for detoxification, mood, cardiovascular health, and energy production insights.
  • Adrenocortex Stress Profile Salivary hormone test assessing the HPA axis through four timed cortisol and DHEA samples across the day to evaluate diurnal cortisol rhythm and adrenal function for clinicians and patients.
  • One Day Hormone Check™ 24-hour salivary hormone test evaluating unbound bioavailable levels of estradiol, estrone, estriol, progesterone, testosterone, cortisol, DHEA, and melatonin in women and men.
  • Women's Health+ Integrated metabolic and endocrine profile combining hormone panels, organic acid nutritional markers, and optional genetic SNPs using saliva, urine, and buccal swab samples for women's health.
  • Endo+ Comprehensive customizable hormonal assessment evaluating thyroid, adrenal, melatonin, and sex hormones along with estrogen metabolism using saliva, serum, or urine samples.
  • Alzheimer's Assessment (p-Tau217) Single-draw blood assessment measuring plasma p-Tau217 for early detection of Alzheimer's-related pathology (amyloid plaques and tau tangles) to support clinical decision-making.
  • Alcat Test Leukocyte reactivity test assessing immune response to foods, additives, chemicals, and other substances for personalized nutrition strategies; newly added to Genova's Immune Function testing menu in 2025.
  • Cardio Check Cardiovascular health assessment panel offered under the Specialty testing category for clinicians and patients.
  • DetoxiGenomic Profile Genomic assessment of detoxification pathways offered under the Specialty testing category for clinicians and patients.
  • Food Sensitivity+ IgG and IgE antibody profile measuring immune responses to commonly consumed foods and environmental allergens, available as a standalone or add-on to GI Effects, Metabolomix+, and Organix.
  • Celiac Profile Comprehensive testing for celiac disease markers offered under the Immune Function category for clinicians and patients.
  • myGDX Provider Portal Web-based provider portal for licensed healthcare professionals to order Genova Diagnostic tests, view pricing, track order status, and access results reports, with cloud-based EHR integration for streamlined ordering and results transmission.
  • Genova Connect (Direct-to-Consumer Storefront) Online direct-to-consumer storefront at connect.gdx.net for individuals to purchase select gut health, nutrition, and hormonal health tests without a physician order, with optional provider matching for result interpretation.

Quantifiable outcome

  • Analysis of more than 300 clinically relevant biomarkers
  • +2 more outcomes

Companies that use Genova Diagnostics

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Genova Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature7 records

Genova Diagnostics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MicrobacoreTechnology or IntegrationGenova collaborates with Microba, who provides world-leading technology in metagenomic analysis and interpretation for the Microbiomix stool analysis product. Microba's Analysis Platform enables detection of over 28,000 species through their unmatched reference database. This partnership enables Genova to offer the most comprehensive gut microbiome testing combining biomarker analysis with genotypic data.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Genova Diagnostics competitors and assessment

Company assessment

Direct peers

  • Doctor's Data: Doctor's Data is a specialty clinical laboratory offering stool-based GI testing, toxic element analysis, and other functional medicine diagnostics. It is one of the closest direct competitors to Genova in the functional/integrative medicine lab space, overlapping on microbiome and nutritional assessment offerings.
  • Mosaic Diagnostics (formerly Great Plains Laboratory): Mosaic Diagnostics is a specialty lab focused on comprehensive stool parasitology, organic acids, and environmental toxin testing serving integrative and functional medicine practitioners. Direct overlap with Genova in gut health, nutrition, and specialty biomarker panels and target clinician base.
  • ZRT Laboratory: ZRT Laboratory specializes in hormone and wellness testing using dried blood spot, saliva, and serum, sold primarily through healthcare providers. Strong overlap with Genova's hormonal health portfolio (Adrenocortex Stress Profile, One Day Hormone Check, Women's Health+).
  • Vibrant Wellness (Vibrant America): Vibrant offers advanced specialty lab testing including food sensitivity, hormones, and gut health panels via provider channels and direct-to-consumer options. Competes head-to-head with Genova in functional medicine and DTC lab testing with strong digital/marketing capabilities.
  • SpectraCell Laboratories: SpectraCell is a clinical laboratory specializing in micronutrient testing, cardiovascular risk panels, and immune-related diagnostics marketed to integrative and preventive medicine practitioners. Overlaps with Genova's NutrEval/Metabolomix nutritional assessment category.
  • Boston Heart Diagnostics: Boston Heart Diagnostics is a specialty lab focused on advanced cardiovascular disease diagnostics sold through healthcare providers. Overlaps with Genova's specialty testing category (Cardio Check) and provider-led specialty lab model.

Broad incumbents

  • Quest Diagnostics (Specialty): Quest Diagnostics is a large national reference laboratory offering routine and specialty diagnostics across endocrinology, gastroenterology, and genetics. As a broad incumbent, Quest could expand into functional-medicine-adjacent specialty testing and compete on insurance coverage, logistics, and brand.
  • Labcorp (Specialty/Wellness): Labcorp is a national reference lab with a growing portfolio in women's health, hormone, and specialty testing. As a broad incumbent with extensive payer contracts and phlebotomy infrastructure, Labcorp represents the scale-tier threat to Genova's niche functional diagnostics.

Others

  • Microba: Microba is Genova's metagenomics technology partner whose Analysis Platform underlies the Microbiomix product. They are adjacent (enabling partner) rather than a direct competitor today, but they are a credible emerging player in gut microbiome analysis that could enter clinical lab services.

Emerging players

  • Access Medical Labs: Access Medical Labs provides specialty diagnostics including hormones, infectious disease, and wellness panels with nationwide servicing. Overlaps with Genova's specialty/hormonal testing menu and competes for provider relationships in the DTC-adjacent segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Genova Diagnostics social profiles

Digital presence

Genova Diagnostics compliance and trust

Trust signal

Compliance2 records

Genova Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genova Diagnostics leadership team

Management profile

Number of profiles

Genova Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genova Diagnostics M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genova Diagnostics

What does Genova Diagnostics do?

Genova Diagnostics is a clinical laboratory that performs advanced specialty diagnostic testing for personalized health, analyzing 300+ biomarkers across gut health, nutrition, hormonal health, immune function, and specialty domains. Tests are ordered primarily by licensed healthcare providers through the myGDX portal and are also accessible directly to consumers through Genova Connect, with specimens (stool, blood, urine, saliva, breath, buccal) processed at the company's Asheville, NC laboratory.

Is Genova Diagnostics a public or private company?

Genova Diagnostics is a private company. It is classified as unknown and is currently operating.

When was Genova Diagnostics founded?

Genova Diagnostics was founded in 1985. It employs 251 to 500 people.

Where is Genova Diagnostics based?

Genova Diagnostics is headquartered in Asheville, United States, in the North America region.

How does Genova Diagnostics make money?

Four revenue lines are on record. Laboratory Diagnostic Testing Services are the primary driver. The others are insurance and Medicare Billing, patient Direct Pay and provider/Clinician Billing.

Who are Genova Diagnostics's main competitors?

Direct peers on record are Doctor's Data, Mosaic Diagnostics (formerly Great Plains Laboratory), ZRT Laboratory, Vibrant Wellness (Vibrant America), SpectraCell Laboratories and Boston Heart Diagnostics. Broad incumbents are Quest Diagnostics (Specialty) and Labcorp (Specialty/Wellness). Microba is listed as an others. Access Medical Labs is listed as an emerging player.

Does Genova Diagnostics have an API?

No public API is recorded for Genova Diagnostics.

What industry is Genova Diagnostics in?

Genova Diagnostics's product category is Clinical Laboratory Diagnostics. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nutritional OutlookSeraphina Therapeutics partners with Genova Diagnostics to introduce at-home test that measures levels of pentadecanoic acidSeraphina Therapeutics has partnered with Genova Diagnostics to launch the Fatty15 C15:0 Test, an at-home diagnostic for measuring pentadecanoic acid levels linked to Cellular Fragility Syndrome. The test enables consumers to assess their nutritional status and potentially adjust diets or use Seraphina's fatty15 supplements to address deficiencies.GlobeNewswireCellular Health Screening Market Size to Reach USD 10.65 Billion by 2035 | SNS InsiderThe cellular health screening market was valued at USD 3.89 billion in 2025 and is projected to reach USD 10.65 billion by 2035, a CAGR of 10.60%. Blood tests held the largest sample-type share at 48%, while single-test panels led with 81% of test-type share. North America accounted for 47% of global revenue in 2025.citybizGenova Diagnostics Names Keith Meadors Chief Commercial Officer Following Strategic Search by CollectiveMindsGenova Diagnostics has appointed Keith Meadors as Chief Commercial Officer, a veteran healthcare executive with over 30 years of experience in diagnostics, pharmaceuticals, and medical devices, most recently serving as VP and General Manager at Labcorp. The appointment comes as Genova seeks to scale its commercial operations following its January 2026 acquisition of Cell Science Systems, which expanded the company's testing capabilities in the competitive diagnostic services market. Meadors will oversee revenue strategy, customer relationships, and market expansion across Genova's diagnostic testing portfolio spanning gut health, hormonal testing, immunology, and genomics.PR NewswireCollectiveMinds LLC Places Keith Meadors as Chief Commercial Officer at Genova DiagnosticsExecutive search firm CollectiveMinds LLC has placed Keith Meadors as Chief Commercial Officer at Genova Diagnostics, a company specializing in advanced diagnostic testing. Meadors brings over 30 years of healthcare industry experience, most recently serving as Vice President and General Manager at Labcorp where he held P&L accountability for the South Atlantic region. The appointment supports Genova's continued growth following its acquisition of Cell Science Systems in January 2026 and is backed by private equity firm Levine Leichtman Capital Partners.PR NewswireGenova Diagnostics Names Keith Meadors Chief Commercial Officer to Support Next Phase of GrowthGenova Diagnostics has appointed Keith Meadors as Chief Commercial Officer, effective immediately. Meadors brings over 30 years of healthcare executive experience, most recently serving as Vice President and General Manager at Labcorp with full P&L accountability for the South Atlantic region. The appointment follows Genova's acquisition of Cell Science Systems in January 2026 and is supported by ownership group Levine Leichtman Capital Partners as part of the company's growth strategy.EIN PresswireMicrobiome Testing Kit Market: Future Demand and Top Key Players Analysis | 2029The Business Research Company published a market report on the global microbiome testing kit industry, projecting the market to grow from $1.31 billion in 2024 to $1.63 billion in 2025 (24.5% CAGR), reaching $3.88 billion by 2029. Growth drivers include rising demand for personalized healthcare, increased adoption of at-home self-tests, and growing investments in microbiome therapeutics. The report identifies major industry players including OraSure Technologies Inc., Genova Diagnostics Inc., Viome Inc., and Zymo Research Corporation, while noting CJ Bioscience Inc. launched a next-generation sequencing-based gut microbiome test kit in South Korea in January 2025.PR NewswireKihealth and Genova Diagnostics Partner to Make Comprehensive Gut Health Testing Easier and More AccessibleKihealth and Genova Diagnostics partnered to make gut health testing available through retail pharmacies and online. The tests provide comprehensive stool analysis covering inflammation, microbiome, and mucosal integrity. Kihealth aims to launch its full suite of preventative diagnostics by mid-2025.PR NewswireCellular Health Screening Market Research Report by Test Type, by Sample Type - Global Forecast to 2025 - Cumulative Impact of COVID-19ReportLinker has published a market research report forecasting the global Cellular Health Screening Market to reach USD 3,740.69 Million by 2025, growing at a CAGR of 10.71% from 2019. The study analyzes market segmentation by test and sample types, geographic regions, and the cumulative impact of COVID-19 on industry growth. It provides competitive intelligence on key vendors including Bio-Reference Laboratories, Cell Science Systems, Cleveland HeartLab, Genova Diagnostics, LabCorp, Life Length, Quest Diagnostics, and SpectraCell Laboratories.PR NewswireNew Noninvasive Nutritional Testing with Metabolomix+Genova Diagnostics introduced a new collect-at-home nutritional test called Metabolomix+ to support telemedicine practices and provide clinicians comprehensive testing options without requiring a blood draw.PR NewswireThe Lab Report Podcast: Connecting Lab Testing with Personalized Medicine and Optimized HealthGenova Diagnostics has launched "The Lab Report," a new podcast series focused on personalized medicine, laboratory testing, and functional medicine topics, with new episodes released on Tuesdays and Fridays. The podcast is hosted by Dr. Patti Devers and Dr. Michael Chapman, who interview notable figures in the functional medicine and health wellness arena. Genova Diagnostics, a clinical laboratory testing company established in 1986, is presenting the podcast as an educational resource for clinicians, patients, and industry professionals.